☆ 4.6 Letter

Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing

ALLERGY (2021)

Get Full Text
Add to Collection

Journal

ALLERGY
Volume 76, Issue 8, Pages 2605-2607

Publisher

WILEY
DOI: 10.1111/all.14839

Keywords

adverse drug reaction; intradermal test; SARS‐ CoV‐ 2 vaccine; skin test

Categories

Allergy Immunology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.